Skip to main content
. 2017 May 29;2017:4649191. doi: 10.1155/2017/4649191

Figure 4.

Figure 4

The docking result of the EGFR inhibitors with EGFR. (a) The binding site of compound 27 with EGFR is Thr766. (b) The binding site of compound 28 with EGFR is Met769. (c) The binding site of compound 30 with EGFR is Met769. (d) The binding site of compound 31 with EGFR is Met769. (e) The binding site of compound 32 with EGFR is Met769. (f) The binding sites of compound 33 with EGFR is Thr766 and Met769.